Moderna Inc
Stocks making the biggest moves premarket: Apple, Estee Lauder, Roku, Reddit, Roblox and more
Check out the companies making the biggest moves premarket: Apple — Shares were up 3.5%. For the fiscal second quarter , Apple’s earnings came in at $2.01 per share, while revenue landed at $111.18 billion. This beat the earnings of $1.95 a share and $109.66 billion in revenue analysts were looking for, per LSEG. Still, […]
Read More
Stock futures rise after the S&P 500 hits a record to wrap April’s trading: Live updates
Traders work on the floor of the New York Stock Exchange on April 30, 2026. NYSE U.S. stock futures rose on Thursday night after the S&P 500 and Nasdaq Composite rose to new intraday and closing highs to round out trading for the month of April. S&P 500 futures and Nasdaq 100 futures climbed around […]
Read More
Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy
Rear Admiral Erica G. Schwartz. U.S. Department of Health and Human Services President Donald Trump on Thursday nominated Erica Schwartz to serve as director of the Centers for Disease Control and Prevention, concluding a monthslong effort to choose a permanent leader of the embattled health agency. Schwartz will have to be confirmed by the Senate, […]
Read More
Salesforce won’t be discarded in the AI boom, but what companies want is changing
Companies are not going to abandon Salesforce altogether in the age of artificial intelligence, but they are changing how they use it and what they expect. For Morgan DeBaun, CEO and co-founder of digital media group Blavity, cost-saving enabled by AI is a major factor in how she views Salesforce going forward. Blavity, which aims […]
Read More
Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs
The Trump administration is preparing to impose new tariffs on branded drugs from pharmaceutical companies that have not struck landmark deals with the president to lower their U.S. drug prices, CNBC has learned. Patented medications and their active ingredients would be hit with a 100% tariff, according to a draft of the document obtained by […]
Read More
Oil prices top $100, FDA leadership change, the wellness boom and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Good morning. If you’re getting on a plane soon, consider this a public service announcement that you may want to give yourself extra time for security lines. Stock futures are tanking this morning following a losing week on Wall Street. Here are […]
Read More
FDA vaccine head will step down in April after string of controversial decisions
The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]
Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration. The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]
Read More
Stocks making the biggest moves premarket: Moderna, Ross Stores, Box, Gitlab and more
Check out the companies making headlines before the bell. Moderna — The biotechnology firm’s stock rose nearly 11% after it said it agreed to pay up to $2.25 billion to settle with Biopharma Corporation and Genevant Sciences GmbH a lawsuit over a Covid vaccine patent dispute. Ross Stores — Shares popped 7% after the off-price […]
Read More
AI disruption didn’t show up in Salesforce results. But the fears are hard to shake
Salesforce on Wednesday evening delivered better-than-expected 2026 fourth-quarter results as its Agentforce artificial intelligence platform became increasingly embedded across the business. However, the stock dropped in after-hours trading as investors remained anxious about the potential of AI disrupting traditional enterprise software companies. Revenue in the quarter ended Jan. 31 rose 12% year over year to […]
Read More